Thermal ablation to destroy tumor tissue may help activate tumor-specific T cells by elevating
the presentation of tumor antigens to the immune system. However, the antitumor activity of …

B7 family proteins provide costimulatory signals that regulate T cell responses. Here we
report the third set of B7 family-related T cell inhibitory molecules with the identification of a …

B7-H3 and B7x are members of the B7 family of immune regulatory ligands that are thought
to attenuate peripheral immune responses through co-inhibition. Previous studies have …

IL-15 has potential as an immunotherapeutic agent for cancer treatment because of its
ability to effectively stimulate CD8 T cell, natural killer T cell, and natural killer cell immunity. …

As Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to spread,
characterization of its antibody epitopes, emerging strains, related coronaviruses, and even …

Discovery of immunologically relevant antigens in prostate cancer forms the basis for
developing more potent active immunotherapy. We report here a strategy using the transgenic …

Original research: Phase Ib study of patients with metastatic castrate-resistant prostate cancer
treated with different sequencing regimens of atezolizumab and sipuleucel-T - PMC Back …

Radiofrequency (RF) ablation may have the potential to turn a patient's tumor into an endogenous
tumor vaccine; in this context of RF ablation–triggered immune system stimulation, the …

IL-15 has potential as an immunotherapeutic agent for cancer treatment because it is a critical
factor for the proliferation and activation of NK and CD8+ T cells. However, monotherapy …

The costimulatory molecules B7-H3 and B7-H4 are overexpressed in a variety of human
tumors and have been hypothesized as possible biomarkers and immunotherapeutic targets. …